var eventsData = [{"Ticker":"XRAY","EffectiveDate":"2016-12-28","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":"-1.42%","FiveDayReturnAfter":"0.18%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"XRAY","EffectiveDate":"2016-12-05","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":"0.63%","FiveDayReturnAfter":"3.64%","FiveDayReturnBefore":"-6.52%"},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.76%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"6.45%"},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.76%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"6.45%"},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2016 Q3's earning $0.66 per share and revenue $954.2MM. This beats analyst's estimated EPS $0.63, misses estimated revenue $968.1MM.","DailyReturn":"1.76%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"6.45%"},{"Ticker":"XRAY","EffectiveDate":"2016-11-01","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades XRAY to Overweight from Equal-Weight.","DailyReturn":"1.44%","FiveDayReturnAfter":"5.98%","FiveDayReturnBefore":"-0.7%"},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"6.73%","FiveDayReturnBefore":"-6.17%"},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"6.73%","FiveDayReturnBefore":"-6.17%"},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"6.73%","FiveDayReturnBefore":"-6.17%"},{"Ticker":"XRAY","EffectiveDate":"2016-09-28","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"-0.03%"},{"Ticker":"XRAY","EffectiveDate":"2016-09-22","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on XRAY to Neutral.","DailyReturn":"0.2%","FiveDayReturnAfter":"-0.28%","FiveDayReturnBefore":"1.1%"},{"Ticker":"XRAY","EffectiveDate":"2016-08-08","Type":"RatingNeutral","Title":"Barrington Research downgrades XRAY to Market Perform from Outperform.","DailyReturn":"-1.75%","FiveDayReturnAfter":"-1.57%","FiveDayReturnBefore":"-3.25%"},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2016 Q2's earning $0.76 per share and revenue $1022MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1030MM.","DailyReturn":"-2.66%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"0.93%"},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.66%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"0.93%"},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.66%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"0.93%"},{"Ticker":"XRAY","EffectiveDate":"2016-06-27","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-3.16%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"-2.94%"},{"Ticker":"XRAY","EffectiveDate":"2016-06-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.16%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"-2.94%"},{"Ticker":"XRAY","EffectiveDate":"2016-06-22","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":"0.23%","FiveDayReturnAfter":"-4.47%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"XRAY","EffectiveDate":"2016-06-13","Type":"RatingNeutral","Title":"PiperJaffray initiates coverage on XRAY to Overweight.","DailyReturn":"1.76%","FiveDayReturnAfter":"-0.63%","FiveDayReturnBefore":"1.52%"},{"Ticker":"XRAY","EffectiveDate":"2016-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"1.2%","FiveDayReturnBefore":"1.68%"},{"Ticker":"XRAY","EffectiveDate":"2016-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"1.2%","FiveDayReturnBefore":"1.68%"},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.08%","FiveDayReturnAfter":"2.3%","FiveDayReturnBefore":"0.26%"},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.08%","FiveDayReturnAfter":"2.3%","FiveDayReturnBefore":"0.26%"},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"EarningsRevenueBeat","Title":"Before market open, XRAY reports 2016 Q1's earning $0.69 per share and revenue $772.6MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $734.75MM.","DailyReturn":"2.08%","FiveDayReturnAfter":"2.3%","FiveDayReturnBefore":"0.26%"},{"Ticker":"XRAY","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"Morgan Stanley downgrades XRAY to Equal-Weight from Overweight. Target Price is $65.","DailyReturn":"-1.53%","FiveDayReturnAfter":"1.76%","FiveDayReturnBefore":"-1.08%"},{"Ticker":"XRAY","EffectiveDate":"2016-03-22","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":"1.64%","FiveDayReturnAfter":"3.37%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"XRAY","EffectiveDate":"2016-03-15","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on XRAY to Outperform. Target Price is $70.","DailyReturn":"-0.83%","FiveDayReturnAfter":"-2.32%","FiveDayReturnBefore":"0.66%"},{"Ticker":"XRAY","EffectiveDate":"2016-03-14","Type":"RatingNeutral","Title":"William Blair downgrades XRAY to Market Perform from Outperform.","DailyReturn":"-3.27%","FiveDayReturnAfter":"-4.46%","FiveDayReturnBefore":"5.38%"},{"Ticker":"XRAY","EffectiveDate":"2016-03-03","Type":"RatingUpgrade","Title":"Jefferies upgrades XRAY to Buy from Neutral. Target Price is $70; previously $60.","DailyReturn":"0.69%","FiveDayReturnAfter":"3.12%","FiveDayReturnBefore":"3.93%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"7.35%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-25","Type":"RatingUpgrade","Title":"UBS upgrades XRAY to Neutral from Sell. Target Price is $60.","DailyReturn":"4.94%","FiveDayReturnAfter":"3.93%","FiveDayReturnBefore":"3.46%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.14%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-4.85%"},{"Ticker":"XRAY","EffectiveDate":"2016-02-12","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-3.14%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-4.85%"},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.94%","FiveDayReturnAfter":"-0.88%","FiveDayReturnBefore":"-6.55%"},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-1.94%","FiveDayReturnAfter":"-0.88%","FiveDayReturnBefore":"-6.55%"},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.94%","FiveDayReturnAfter":"-0.88%","FiveDayReturnBefore":"-6.55%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-22","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":"1%","FiveDayReturnAfter":"3.17%","FiveDayReturnBefore":"0.61%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.77%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"-2.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.03%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"-2.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-11-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.27%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"2.38%"},{"Ticker":"XRAY","EffectiveDate":"2015-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.27%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"2.38%"},{"Ticker":"XRAY","EffectiveDate":"2015-11-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.46%","FiveDayReturnAfter":"2.38%","FiveDayReturnBefore":"-3.13%"},{"Ticker":"XRAY","EffectiveDate":"2015-11-13","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.46%","FiveDayReturnAfter":"2.38%","FiveDayReturnBefore":"-3.13%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.19%","FiveDayReturnAfter":"4.55%","FiveDayReturnBefore":"2.59%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-29","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"2.19%","FiveDayReturnAfter":"4.55%","FiveDayReturnBefore":"2.59%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.45%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"3.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.45%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"3.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.45%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"3.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.45%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"3.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-23","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":"1.01%","FiveDayReturnAfter":"-3.72%","FiveDayReturnBefore":"-3.44%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-21","Type":"RatingUpgrade","Title":"William Blair upgrades XRAY to Outperform.","DailyReturn":"0.47%","FiveDayReturnAfter":"-1.65%","FiveDayReturnBefore":"0.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-21","Type":"RatingUpgrade","Title":"Northcoast Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":"0.47%","FiveDayReturnAfter":"-1.65%","FiveDayReturnBefore":"0.51%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingUpgrade","Title":"Baird upgrades XRAY to Outperform. Target Price is $61; previously $58.","DailyReturn":"-2.35%","FiveDayReturnAfter":"-3.44%","FiveDayReturnBefore":"3.63%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform. Target Price is $60.","DailyReturn":"-2.35%","FiveDayReturnAfter":"-3.44%","FiveDayReturnBefore":"3.63%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingNeutral","Title":"Bank of America maintains XRAY to Buy. Target Price is $65; previously $60.","DailyReturn":"-2.35%","FiveDayReturnAfter":"-3.44%","FiveDayReturnBefore":"3.63%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"4.61%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"4.61%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"4.61%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"4.61%"},{"Ticker":"XRAY","EffectiveDate":"2015-09-14","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades XRAY to Overweight.","DailyReturn":"1.95%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"1.76%"},{"Ticker":"XRAY","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Credit Suisse maintains XRAY to Outperform. Target Price is $63; previously $61.","DailyReturn":"1.51%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"6.14%"},{"Ticker":"XRAY","EffectiveDate":"2015-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"4.31%","FiveDayReturnAfter":"4.9%","FiveDayReturnBefore":"2.2%"},{"Ticker":"XRAY","EffectiveDate":"2015-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.31%","FiveDayReturnAfter":"4.9%","FiveDayReturnBefore":"2.2%"},{"Ticker":"XRAY","EffectiveDate":"2015-06-24","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":"-1.54%","FiveDayReturnAfter":"-2.82%","FiveDayReturnBefore":"2.18%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-22","Type":"Item_2.05","Title":"Costs Associated with Exit or Disposal Activities\r\n","DailyReturn":"-0.97%","FiveDayReturnAfter":"-0.63%","FiveDayReturnBefore":"1.44%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.97%","FiveDayReturnAfter":"-0.63%","FiveDayReturnBefore":"1.44%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.47%","FiveDayReturnBefore":"4.17%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.47%","FiveDayReturnBefore":"4.17%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.47%","FiveDayReturnBefore":"4.17%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.47%","FiveDayReturnBefore":"4.17%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.37%","FiveDayReturnAfter":"-3.19%","FiveDayReturnBefore":"1.25%"},{"Ticker":"XRAY","EffectiveDate":"2015-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.37%","FiveDayReturnAfter":"-3.19%","FiveDayReturnBefore":"1.25%"},{"Ticker":"XRAY","EffectiveDate":"2015-03-25","Type":"Dividend","Title":"The Firm pays dividend $0.072","DailyReturn":"-1.96%","FiveDayReturnAfter":"-1.59%","FiveDayReturnBefore":"1.26%"},{"Ticker":"XRAY","EffectiveDate":"2015-02-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.72%","FiveDayReturnAfter":"-0.15%","FiveDayReturnBefore":"5.14%"},{"Ticker":"XRAY","EffectiveDate":"2015-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.72%","FiveDayReturnAfter":"-0.15%","FiveDayReturnBefore":"5.14%"},{"Ticker":"XRAY","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Barrington Research assumes XRAY to Market Perform.","DailyReturn":"1.47%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-3.83%"},{"Ticker":"XRAY","EffectiveDate":"2015-01-02","Type":"RatingNeutral","Title":"Baird downgrades XRAY to Neutral from Outperform. Target Price is $55.","DailyReturn":"-2.51%","FiveDayReturnAfter":"0.5%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"XRAY","EffectiveDate":"2014-12-23","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":"-0.04%","FiveDayReturnAfter":"-1.27%","FiveDayReturnBefore":"1.26%"},{"Ticker":"XRAY","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Credit Suisse maintains XRAY to Outperform. Target Price is $55; previously $54.","DailyReturn":"1.56%","FiveDayReturnAfter":"4.55%","FiveDayReturnBefore":"8.01%"},{"Ticker":"XRAY","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.65%","FiveDayReturnAfter":"6.48%","FiveDayReturnBefore":"3.5%"},{"Ticker":"XRAY","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.65%","FiveDayReturnAfter":"6.48%","FiveDayReturnBefore":"3.5%"},{"Ticker":"XRAY","EffectiveDate":"2014-10-20","Type":"RatingNeutral","Title":"Goldman Sachs downgrades XRAY to Neutral from Buy.","DailyReturn":"-1.19%","FiveDayReturnAfter":"1.83%","FiveDayReturnBefore":"0.82%"},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":"1.1%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.1%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"XRAY","EffectiveDate":"2014-07-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.15%","FiveDayReturnAfter":"-1.29%","FiveDayReturnBefore":"1.33%"},{"Ticker":"XRAY","EffectiveDate":"2014-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.15%","FiveDayReturnAfter":"-1.29%","FiveDayReturnBefore":"1.33%"},{"Ticker":"XRAY","EffectiveDate":"2014-06-25","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":"1.1%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"-0.27%"},{"Ticker":"XRAY","EffectiveDate":"2014-05-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.88%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"XRAY","EffectiveDate":"2014-05-21","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.88%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"XRAY","EffectiveDate":"2014-05-16","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":"0.93%","FiveDayReturnAfter":"2%","FiveDayReturnBefore":"0.63%"},{"Ticker":"XRAY","EffectiveDate":"2014-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.11%","FiveDayReturnBefore":"1.97%"},{"Ticker":"XRAY","EffectiveDate":"2014-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.11%","FiveDayReturnBefore":"1.97%"},{"Ticker":"XRAY","EffectiveDate":"2014-03-26","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":"-0.03%","FiveDayReturnAfter":"3.27%","FiveDayReturnBefore":"-0.72%"},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.18%","FiveDayReturnAfter":"-2.47%","FiveDayReturnBefore":"1.37%"},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"RevenueBeat","Title":"After market close, XRAY reports 2013 Q4's earning $0.61 per share and revenue $753.7MM. This meets analyst's estimated EPS $0.61, misses estimated revenue $767.89MM.","DailyReturn":"-1.18%","FiveDayReturnAfter":"-2.47%","FiveDayReturnBefore":"1.37%"},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.18%","FiveDayReturnAfter":"-2.47%","FiveDayReturnBefore":"1.37%"},{"Ticker":"XRAY","EffectiveDate":"2013-12-24","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":"-0.11%","FiveDayReturnAfter":"-0.65%","FiveDayReturnBefore":"2.46%"},{"Ticker":"XRAY","EffectiveDate":"2013-12-11","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades XRAY to Buy from Neutral. Target Price is $56; previously $45.","DailyReturn":"0.87%","FiveDayReturnAfter":"-1.27%","FiveDayReturnBefore":"1.78%"},{"Ticker":"XRAY","EffectiveDate":"2013-12-11","Type":"RatingUpgrade","Title":"Credit Suisse upgrades XRAY to Outperform from Neutral.","DailyReturn":"0.87%","FiveDayReturnAfter":"-1.27%","FiveDayReturnBefore":"1.78%"},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.62%","FiveDayReturnAfter":"5.34%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2013 Q3's earning $0.57 per share and revenue $704MM. This beats analyst's estimated EPS $0.56, misses estimated revenue $716.13MM.","DailyReturn":"1.62%","FiveDayReturnAfter":"5.34%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.62%","FiveDayReturnAfter":"5.34%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"XRAY","EffectiveDate":"2013-10-04","Type":"RatingUpgrade","Title":"Bank of America upgrades XRAY to Buy from Underperform. Target Price is $48; previously $35.","DailyReturn":"2.93%","FiveDayReturnAfter":"1.99%","FiveDayReturnBefore":"-0.66%"},{"Ticker":"XRAY","EffectiveDate":"2013-09-25","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":"-0.97%","FiveDayReturnAfter":"-0.54%","FiveDayReturnBefore":"-1.33%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-27","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.64%","FiveDayReturnAfter":"-0.23%","FiveDayReturnBefore":"0.73%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.64%","FiveDayReturnAfter":"-0.23%","FiveDayReturnBefore":"0.73%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-06","Type":"RatingNeutral","Title":"Northcoast Research downgrades XRAY to Neutral from Buy.","DailyReturn":"-0.28%","FiveDayReturnAfter":"0.02%","FiveDayReturnBefore":"1.41%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2013 Q2's earning $0.66 per share and revenue $761.01MM. This beats analyst's estimated EPS $0.65, misses estimated revenue $782.73MM.","DailyReturn":"0.04%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"1.31%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"1.31%"},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"1.31%"},{"Ticker":"XRAY","EffectiveDate":"2013-06-26","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":"0.72%","FiveDayReturnAfter":"2.27%","FiveDayReturnBefore":"-3.75%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-23","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.09%","FiveDayReturnAfter":"1.26%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-23","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.09%","FiveDayReturnAfter":"1.26%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-20","Type":"RatingNeutral","Title":"Barrington Research downgrades XRAY to Market Perform from Outperform.","DailyReturn":"-0.23%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-0.84%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-09","Type":"EarningsRevenueMiss","Title":"Before market open, XRAY reports 2013 Q1's earning $0.52 per share and revenue $732.1MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $732.87MM.","DailyReturn":"-3.95%","FiveDayReturnAfter":"-3.85%","FiveDayReturnBefore":"5.53%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.86%","FiveDayReturnAfter":"-1.36%","FiveDayReturnBefore":"2.42%"},{"Ticker":"XRAY","EffectiveDate":"2013-05-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.86%","FiveDayReturnAfter":"-1.36%","FiveDayReturnBefore":"2.42%"},{"Ticker":"XRAY","EffectiveDate":"2013-04-15","Type":"RatingUpgrade","Title":"Citigroup upgrades XRAY to Buy from Neutral. Target Price is $49; previously $39.65.","DailyReturn":"-2.02%","FiveDayReturnAfter":"-1.14%","FiveDayReturnBefore":"3.16%"},{"Ticker":"XRAY","EffectiveDate":"2013-04-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"-4.11%"},{"Ticker":"XRAY","EffectiveDate":"2013-04-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"-4.11%"},{"Ticker":"XRAY","EffectiveDate":"2013-03-26","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":"0.7%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"0%"},{"Ticker":"XRAY","EffectiveDate":"2013-02-21","Type":"RatingNeutral","Title":"Wellington Shields downgrades XRAY to Hold from Gradually Accumulate.","DailyReturn":"-3.93%","FiveDayReturnAfter":"-4.03%","FiveDayReturnBefore":"0.3%"},{"Ticker":"XRAY","EffectiveDate":"2013-02-21","Type":"RatingNeutral","Title":"UBS maintains XRAY to Sell. Target Price is $38; previously $35.","DailyReturn":"-3.93%","FiveDayReturnAfter":"-4.03%","FiveDayReturnBefore":"0.3%"},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.12%","FiveDayReturnAfter":"-6.18%","FiveDayReturnBefore":"1.5%"},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.12%","FiveDayReturnAfter":"-6.18%","FiveDayReturnBefore":"1.5%"},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"EarningsRelease","Title":"Before market open, XRAY reports 2012 Q4's earning $0.56 per share and revenue $753.3MM. This meets analyst's estimated EPS $0.56, beats estimated revenue $742.7MM.","DailyReturn":"-1.12%","FiveDayReturnAfter":"-6.18%","FiveDayReturnBefore":"1.5%"},{"Ticker":"XRAY","EffectiveDate":"2012-12-26","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":"-1.21%","FiveDayReturnAfter":"1.2%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"XRAY","EffectiveDate":"2012-11-08","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on XRAY to Hold.","DailyReturn":"-1.63%","FiveDayReturnAfter":"-1.72%","FiveDayReturnBefore":"4.74%"},{"Ticker":"XRAY","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, XRAY reports 2012 Q3's earning $0.37 per share and revenue $695.73MM..","DailyReturn":"1.68%","FiveDayReturnAfter":"3.53%","FiveDayReturnBefore":"-3.79%"},{"Ticker":"XRAY","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.49%","FiveDayReturnAfter":"5.85%","FiveDayReturnBefore":"-3.87%"},{"Ticker":"XRAY","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.49%","FiveDayReturnAfter":"5.85%","FiveDayReturnBefore":"-3.87%"},{"Ticker":"XRAY","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"UBS downgrades XRAY to Sell from Neutral. Target Price is $35; previously $39.","DailyReturn":"-1.32%","FiveDayReturnAfter":"0.67%","FiveDayReturnBefore":"-0.27%"},{"Ticker":"XRAY","EffectiveDate":"2012-09-26","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":"-0.27%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"1.22%"},{"Ticker":"XRAY","EffectiveDate":"2012-08-01","Type":"RatingNeutral","Title":"Jefferies maintains XRAY to Buy. Target Price is $44; previously $46.","DailyReturn":"-0.57%","FiveDayReturnAfter":"5.07%","FiveDayReturnBefore":"2.16%"},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.44%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.1%"},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.44%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.1%"},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"EarningsRevenueBeat","Title":"Before market open, XRAY reports 2012 Q2's earning $0.62 per share and revenue $763MM. This beats analyst's estimated EPS $0.57, beats estimated revenue $747.92MM.","DailyReturn":"-2.44%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.1%"},{"Ticker":"XRAY","EffectiveDate":"2012-07-03","Type":"RatingNeutral","Title":"UBS initiates coverage on XRAY to Neutral. Target Price is $41.","DailyReturn":"-0.5%","FiveDayReturnAfter":"-4.14%","FiveDayReturnBefore":"3.42%"},{"Ticker":"XRAY","EffectiveDate":"2012-06-27","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":"1.18%","FiveDayReturnAfter":"3.08%","FiveDayReturnBefore":"-4.61%"},{"Ticker":"XRAY","EffectiveDate":"2012-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"1.15%","FiveDayReturnAfter":"-4.97%","FiveDayReturnBefore":"0.57%"},{"Ticker":"XRAY","EffectiveDate":"2012-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.15%","FiveDayReturnAfter":"-4.97%","FiveDayReturnBefore":"0.57%"},{"Ticker":"XRAY","EffectiveDate":"2012-05-02","Type":"RatingNeutral","Title":"Jefferies maintains XRAY to Buy. Target Price is $46; previously $45.","DailyReturn":"-0.66%","FiveDayReturnAfter":"-2.57%","FiveDayReturnBefore":"1.39%"},{"Ticker":"XRAY","EffectiveDate":"2012-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-4.86%","FiveDayReturnBefore":"4.45%"},{"Ticker":"XRAY","EffectiveDate":"2012-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-4.86%","FiveDayReturnBefore":"4.45%"},{"Ticker":"XRAY","EffectiveDate":"2012-03-28","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":"-0.06%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"2.37%"},{"Ticker":"XRAY","EffectiveDate":"2012-02-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.83%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"2.27%"},{"Ticker":"XRAY","EffectiveDate":"2012-02-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.83%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"2.27%"}];